MRSA Carrier State: Definition, Risks, and Decolonization Strategies

An MRSA carrier (colonized individual) harbors methicillin-resistant Staphylococcus aureus without signs of infection. Colonization prevalence: 1–2% community; 5–15% healthcare workers; higher in long-term care.

Colonization Sites

  • Anterior nares (primary reservoir: 80–90%)
  • Pharynx, perineum, axillae, groin, rectum
  • Skin folds, wounds, device sites

Clinical Significance

  • Autoinfection risk: Carrier → surgical site infection (SSI) OR 3–5×; bacteremia, pneumonia
  • Transmission: Hands, fomites → other patients (especially ICU, NICU, burn units)
  • Outbreak marker: Cluster detection triggers investigation

Screening Indications

  • Pre-operative (orthopedic, cardiac, neurosurgery, vascular)
  • ICU admission (some institutions)
  • Contact of known case
  • Recurrent skin infections
  • Dialysis, cystic fibrosis, immunocompromised

Decolonization Protocol (Perioperative / High-Risk)

  1. Mupirocin 2% calcium ointment intranasal BID × 5 days
  2. Chlorhexidine gluconate 2–4% daily body washes × 5 days (or 2% cloths)
  3. Optional: Oral antiseptic (chlorhexidine rinse)
  4. Verify: Culture 48h after completion (some protocols)

Efficacy and Controversies

  • Reduces SSI by 30–60% in carriers (RCTs)
  • Resistance to mupirocin emerging (monitor)
  • Universal vs. targeted screening debated (cost-effectiveness varies)
  • Community decolonization not routinely recommended

Patient Counseling

  • Carrier ≠ infection; not "dirty"
  • Hand hygiene is primary prevention
  • No work/school restriction
  • Household decolonization not standard (consider if recurrent transmission)

Decolonization is a targeted, evidence-based intervention—not for everyone, but high-value in surgical and critical care pathways.

Nursing Homes - Related Articles